ALN-FLU01

N/A

Report date: 2023/01/08 10:16:22
NME

Base Information

Drug NameALN-FLU01
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionVirus replication inhibitorsRNA interference
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals IncNovartis Pharma AgUniversity Of Georgia
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgAlnylam Pharmaceuticals IncUniversity Of Georgia
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A